Bristol-Myers Squibb buy Piper Sandler
Start price
23.02.26
/
50%
€51.31
Target price
23.02.27
€63.41
Performance (%)
-3.53%
Price
07:52
€49.50
Summary
This prediction is currently active. With a performance of -3.53%, the BUY prediction for Bristol-Myers Squibb by Piper_Sandler is down slightly. This prediction currently runs until 23.02.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 1.336% | 1.336% |
| iShares Core DAX® | -1,86 % | -1,62 % |
| iShares Nasdaq 100 | -3,32 % | 3,32 % |
| iShares Nikkei 225® | -2,30 % | 3,44 % |
| iShares S&P 500 | -1,31 % | 2,44 % |
Comments by Piper_Sandler for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $75.00 price target on the stock, up previously from $66.00.
Ratings data for BMY provided by MarketBeat